By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pharmacogenomic testing startup Foundation Medicine has raised $25 million in a round of Series A financing led by Third Rock Ventures, the Cambridge, Mass.-based firm said today.

The venture financing will be used to develop clinical lab tests that will analyze tumor genomic and other molecular information in individual patients' cancers and link it to a base of clinical oncology data that can help physicians tailor their treatments, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.